LOCALIZATION OF MESSENGER-RIBONUCLEIC-ACID FOR INSULIN-LIKE GROWTH FACTOR-BINDING PROTEINS IN HUMAN SKIN BY IN-SITU HYBRIDIZATION

Citation
Ja. Batch et al., LOCALIZATION OF MESSENGER-RIBONUCLEIC-ACID FOR INSULIN-LIKE GROWTH FACTOR-BINDING PROTEINS IN HUMAN SKIN BY IN-SITU HYBRIDIZATION, The Journal of clinical endocrinology and metabolism, 79(5), 1994, pp. 1444-1449
Citations number
24
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
0021972X
Volume
79
Issue
5
Year of publication
1994
Pages
1444 - 1449
Database
ISI
SICI code
0021-972X(1994)79:5<1444:LOMFIG>2.0.ZU;2-S
Abstract
The role of the insulin-like growth factors (IGFs) in human skin physi ology has been increasingly recognized, although relatively little is known about the cell types involved or the cellular mechanisms that me diate these responses. Epidermal keratinocytes and dermal fibroblasts both possess IGF-I receptors and are responsive to IGF-I. IGF-binding proteins (IGFBPs), known modulators of IGF action, may also be respons ible for targeting IGF-I to its receptors and are produced by both cul tured keratinocytes and fibroblasts. To demonstrate sites of productio n of IGFBPs in human skin, we have used in situ hybridization to local ize messenger ribonucleic acid (mRNA) for the six IGFBPs. Antisense an d sense RNA probes for the IGFBPs (IGFBP-1 to -6) were produced, and 5 -mu m sections of normal adult human male chest skin were probed The c ontrol probe used was keratin-5, which is known to hybridize to the ba sal keratinocytes of the epidermis. mRNAs for human IGFBP-2, -3, -4, a nd -5 were identified, with mRNAs for IGFBP-2 and IGFBP-4 localized in sebaceous glands and eccrine sweat glands (epidermal origin), IGFBP-3 mRNA in the basal layer of the epidermis and mRNAs for IGFBP-4, and I GFBP-5 found throughout the dermis. mRNAs for IGFBP-1 and -6 were not identified in human skin. These studies demonstrate specific localizat ion of IGFBP mRNAs in adult human skin, suggesting that each IGFBP may play a specific role in targeting IGF-I to its receptor on responsive cells and, ultimately, in modulation of IGF-I action in skin.